yingweiwo

PCSK9

PCSK9

PCSK9 related products

Structure Cat No. Product Name CAS No. Product Description
(R,R)-PCSK9 degrader 1 V87650 (R,R)-PCSK9 degrader 1 2216703-12-5 (R,R)-PCSK9 degrader 1 is an isomer of PCSK9 degrader 1.
AZD8233 V87653 AZD8233 2604215-74-7 AZD8233 is a liver-targeting antisense oligonucleotide that inhibits proprotein convertase/subtilisin 9 (PCSK9) protein synthesis.
AZD8233 sodium V87655 AZD8233 sodium AZD8233 sodium is a liver-targeted antisense oligonucleotide that inhibits proprotein convertase/subtilisin/kexin type 9 (PCSK9) protein synthesis.
Cepadacursen sodium V87646 Cepadacursen sodium 2252375-14-5 Cepadacursen sodium is a liver-targeted antisense oligonucleotide that inhibits proprotein convertase/subtilisin/kexin type 9 (PCSK9) protein synthesis.
CVI-LM001 V87648 CVI-LM001 CVI-LM001 is a PCSK9 inhibitor that regulates the level of low-density lipoprotein cholesterol (LDL-C) in the blood by inhibiting the interaction between PCSK9 and low-density lipoprotein receptor (LDLR), thereby exerting a lipid-lowering effect.
DC371739 V87324 DC371739 2135765-21-6 DC371739 is a potent, orally active PCSK9 inhibitor.
E28362 V87654 E28362 930017-01-9 E28362 is a small molecule PCSK9 inhibitor.
PCSK9-IN-26 V87649 PCSK9-IN-26 3033361-09-7 PCSK9-IN-26 (Compound 116) is a PCSK9 inhibitor (IC50 < 1 nM).
PCSK9-IN-27 V87651 PCSK9-IN-27 PCSK9-IN-27 (Compound 108) is a PCSK9 inhibitor (IC50: 3.4 nM).
PCSK9-IN-28 V87652 PCSK9-IN-28 PCSK9-IN-28 (Compound C11) is a PCSK9 inhibitor isolated from Euphorbia esula.
PF-00932239 (R-IMPP) V6648 PF-00932239 (R-IMPP) 2133832-83-2 PF-00932239 (R-IMPP) is a novel and potent inhibitor of PCSK9 translation.
PF-06446846 hydrochloride V27359 PF-06446846 hydrochloride 1632250-50-0 PF‑06446846 HCL (PF-6446846;PF6446846) is a PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor with anti-hyperlipidemic effects.
SBC-110736 V2106 SBC-110736 1629166-02-4 SBC-110736 (SBC110736) is a novel and potent small molecule inhibitor of proprotein convertase subtilisin kexin type 9 (PCSK9) with anti-hyperlipidemic effects.
SBC-115076 V1879 SBC-115076 489415-96-5 SBC-115076 (SBC115076) is a potent extracellular proprotein convertase subtilisin kexin type 9 (PCSK9) antagonist, with the potentialfor the treatment and/or prevention of cardiovascular diseases.
SPC5001 sodium V87645 SPC5001 sodium SPC5001 sodium is a locked nucleic acid (LNA) modified antisense oligonucleotide (ASO) complementary to human PCSK9 (proprotein convertase subtilisin/kexin type 9) mRNA.
SS(no Galnac)-Inclisiran sodium V87647 SS(no Galnac)-Inclisiran sodium SS(no Galnac)-Inclisiran (sodium) is a positive strand of inclisiran without GalNAc modification.
Contact Us